ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Imaging"

  • Abstract Number: 2198 • 2018 ACR/ARHP Annual Meeting

    Evaluation of 18F-Fluorodeoxyglucose PET-CT Score at Baseline on the Therapeutic Response to Prednisone in Polymyalgia Rheumatica: A Retrospective Study

    Nicolas Giraud1, Maxime Sondag2, Aline Charpentier2, Hatem Boulahdour3, Clément Prati4,5, Daniel Wendling6,7 and Frank Verhoeven8, 1Rheumatology, CHU de Besançon, Besançon, France, 2rheumatology, CHU de Besançon, Besancon, France, 3CHU de Besançon, Besançon, France, 4EA 4267 FDE, FHU INCREASE, Université de Bourgogne Franche Comté, Besancon, France, 5Rheumatology, University Hospital - Bourgogne Franche Comté University, Besancon, France, 6Rheumatology, University Hospital - Bourgogne Franche Comté University, Besançon, France, 7EA 4266, Univ. Bourgogne Franche-Comté, F-25000 Besançon, France, F-25000 Besançon, France, 8EA 4267 PEPITE, Université de Bourgogne Franche Comté, Besançon, France

    Background/Purpose: To evaluate the impact of 18F-fluorodeoxyglucose PET-CT (FDG-PET/CT) score at baseline, on the therapeutic response to prednisone, in patients with polymyalgia rheumatica (PMR). Methods:…
  • Abstract Number: 471 • 2018 ACR/ARHP Annual Meeting

    Early Signs of Diastolic Impairment in Children with Incident Systemic Lupus Erythematosus

    Joyce C. Chang1,2, Brian R. White3, Matthew D. Elias3, Rui Xiao4, Andrea M. Knight5,6,7, Pamela F. Weiss8,9,10 and Laura M. Mercer-Rosa3,7, 1Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 3Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, 4Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 5Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, 6Division of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 7Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 8Center for Clinical Epidemiology and Biostastistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 9Division of Rheumatology, Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, 10Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: The timing and etiology of diastolic impairment in pediatric-onset systemic lupus erythematosus (pSLE) are poorly understood, and the role of screening echocardiography remains unclear.…
  • Abstract Number: 2211 • 2018 ACR/ARHP Annual Meeting

    Technetium Tc 99m Tilmanocept: A Targeted Immunodiagnostic Radiopharmaceutical for the Assessment of Synovial Macrophage Activity in Rheumatoid Arthritis

    Arash Kardan1, Allison Kissling2, Bonnie Abbruzzese2, Ahmad Ismail2, Rachael Hershey2, Carley Hartings2, David Ralph2, Izabela Gierach2, Michael Blue2, Hannah Bailey2, Christopher Gablemann2, Katherine Repp2 and Frederick Cope2, 1Charles F. Kettering Memorial Hospital and Wright State University Boonshoft School of Medicine, Dayton, OH, 2Navidea Biopharmaceuticals, Inc., Dublin, OH

    Background/Purpose: Activated macrophages are a critical component of the inflammatory etiology of RA. It is well established that these macrophages perpetuate joint inflammation and destruction…
  • Abstract Number: 666 • 2018 ACR/ARHP Annual Meeting

    Inflammation on MRI of the Sacroiliac Joints Is Highly Associated with Structural Damage in Axial Spondyloarthritis Patients in Clinical Practice: Data from the ASAS and DESIR Cohorts

    Alexandre Sepriano1, Sofia Ramiro1,2, Robert B.M. Landewé3,4, Maxime Dougados5, Désirée van der Heijde6 and Martin Rudwaleit7, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Zuyderland Medical Center, Heerlen & Leiden University Medical Center, Leiden, Netherlands, 3Zuyderland Medical Center, Heerlen, Netherlands, 4Amsterdam Rheumatology & Immunology Center, Amsterdam, the Netherlands, Amsterdam, Netherlands, 5Department of Rheumatology, Paris Descartes University and Cochin Hospital, Paris, France, 6Leiden University Medical Centre, Leiden, Netherlands, 7Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany

    Background/Purpose: The effect of MRI-detected inflammation on the development of radiographic damage at the sacroiliac joints (SIJ) level in patients (pts) with axial SpA (axSpA)…
  • Abstract Number: 2212 • 2018 ACR/ARHP Annual Meeting

    Feasibility and Performance of HR-pQCT-Derived Joint Space Width Measurement As Outcome Parameter in Arthropathic Disease – Lessons from Hemochromatosis Arthropathy

    Ursula Heilmeier1, Andrew J Burghardt1, Puneet Kapoor2, Georg Schett3, Reinhard Voll4 and Stephanie Finzel5, 1Department of Radiology & Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Department of Internal Medicine 3 – Rheumatology and Immunology, University Hospital Erlangen, Erlangen, Germany, 4Clinic for Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany, 5Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

    Background/Purpose: High resolution peripheral quantitative computed tomography (HR-pQCT) allows in vivo 3 D imaging of human joint microstructure and joint space width (JSW) at an…
  • Abstract Number: 677 • 2018 ACR/ARHP Annual Meeting

    Structural Damage Characteristics of Patients with Ankylosing Spondylitis in China

    Weiping Kong1, Caroline Jefferies2, Thomas Learch3, Jinrui Cui4, Xiaowei Gan1, Nan Zhang1, Yingze Zhang1, Jianming Wang1, Qingwen Tao1, Xiaoping Yan1, Michael Weisman5 and Mariko Ishimori6, 1China-Japan Friendship Hospital, Beijing, China, 2Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 3Radiology, Cedars-Sinai Medical Center, Los Angeles, CA, 4Cedars-Sinai Medical Center, Los Angeles, CA, 5Harbor UCLA Medical Center, Los Angeles, CA, 6Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA

    Background/Purpose: Structural damage is a major cause of poor outcomes in patients with ankylosing spondylitis (AS). In China, structural damage characteristics of AS are rarely…
  • Abstract Number: 2222 • 2018 ACR/ARHP Annual Meeting

    Construct Validity of Provisional Remission Criteria for Gout: A Dual Energy CT Study

    Nicola Dalbeth1, Christopher Frampton2, Maple Fung3, Scott Baumgartner3, Savvas Nicolaou4 and Hyon K. Choi5, 1University of Auckland, Auckland, New Zealand, 2University of Otago, Christchurch, New Zealand, 3Formerly Ardea Biosciences, San Diego, CA, 4Radiology, University of British Columbia, Vancouver, BC, Canada, 5Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA

    Background/Purpose: Provisional domains and definitions for gout remission criteria have been proposed using consensus methodology (de Lautour et al, Arthritis Care Res 2016). These criteria…
  • Abstract Number: 760 • 2018 ACR/ARHP Annual Meeting

    Diagnosing SLE Arthritis with Dynamic Diffuse Optical Spectroscopy

    George Danias1, Youngwan Kim2, Alessandro Marone3, Kayla Neville1, Andrea Frantz1, Teja Kapoor4, Laura Geraldino-Pardilla1, Ioannis Kymissis2, Andreas Hielscher2,3,5 and Anca Askanase1, 1Rheumatology, Columbia University Medical Center, New York, NY, 2Electrical Engineering, Columbia University, New York, NY, 3Biomedical Engineering, Columbia University, New York, NY, 4Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 5Radiology, Columbia University Medical Center, New York, NY

    Background/Purpose: SLE arthritis is difficult to evaluate because of the sometimes-evanescent nature of the symptoms and limitations of physical exams and imaging studies. Dynamic diffuse…
  • Abstract Number: 2235 • 2018 ACR/ARHP Annual Meeting

    Monosodium Urate Deposition Distribution in the Knees, Hands, and Feet of Treated Gout Patients: A Dual-Energy CT Study

    Chio Yokose1, Nicola Dalbeth2, Savvas Nicolaou3, Scott Baumgartner4, Jia Hu5, Maple Fung4, F. Joseph Simeone6 and Hyon K. Choi1, 1Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, 2University of Auckland, Auckland, New Zealand, 3Radiology, University of British Columbia, Vancouver, BC, Canada, 4Formerly Ardea Biosciences, San Diego, CA, 5Heron Therapeutics, San Diego, CA, 6Department of Radiology, Massachusetts General Hospital, Boston, MA

    Background/Purpose: Prior studies have demonstrated that monosodium urate (MSU) deposits on dual-energy CT (DECT) are commonly found in joints as well as tendons of the…
  • Abstract Number: 798 • 2018 ACR/ARHP Annual Meeting

    Predominant Fasciitis and Mild Intramuscular Edema on Muscle Magnetic Resonance Imaging in Scleroderma-Associated Myopathy

    Julie J. Paik1, Shivani Ahlawat2, Filippo DelGrande3, Laura K. Hummers4, Fredrick M. Wigley4, Ami A. Shah4, Andrew Mammen5 and Laura Fayad6, 1Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Johns Hopkins University, Baltimore, MD, 4Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 5National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 6Radiology, Johns Hopkins University, Baltimore, MD

    Background/Purpose: Skeletal myopathy in systemic sclerosis is poorly defined. The spectrum of muscle histopathology in systemic sclerosis has been previously studied and shown to be…
  • Abstract Number: 2924 • 2018 ACR/ARHP Annual Meeting

    Spinal Radiographic Progression in Early Axial Spondyloarthritis: 5-Year Data from the DESIR Cohort

    Sofia Ramiro1, Désirée van der Heijde2, Alexandre Sepriano3, Miranda van Lunteren4, Anna Molto5, Maria Antonietta D'Agostino6, Damien Loeuille7, Maxime Dougados8, M. Reijnierse9 and Pascal Claudepierre10, 1Zuyderland Medical Center, Heerlen & Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Centre, Leiden, Netherlands, 3Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, 6Department of Rheumatology, Assistance publique-Hôpitaux de Paris Ambroise Paré Hospital, Boulogne-Billancourt , Université Versailles Saint Quentin en Yvelines, Paris, France, 7Rheumatology, University Hospital of Nancy, NANCY, France, 8Department of Rheumatology, Paris Descartes University and Cochin Hospital, Paris, France, 9Radiology, Leiden University Medical Center, Leiden, Netherlands, 10Hôpital Henri Mondor, Créteil, France

    Background/Purpose: Spinal radiographic progression has been investigated in patients with r-axSpA, but not yet as thoroughly in early axSpA. We aimed to analyse the progression…
  • Abstract Number: 865 • 2018 ACR/ARHP Annual Meeting

    Structural and Microstructural Intraarticular Bone Changes at the Metacarpal Heads in Patients with Psoriatic Arthritis Compared to Controls: A HR-pQCT Study

    Dongze Wu1, James F Griffith2, Steven H.M. Lam1, Jiang Yue1, Priscilla Wong1, Lin Shi3, Edmund Li1, Isaac T. Cheng1, Tena K. Li1, Tracy Y. Zhu4, Vivian W. Hung4, Ling Qin5 and Lai-Shan Tam6, 1Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China, Hong Kong, China, 2Department of Imaging and Interventional Radiology, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China, 3Research Centre for Medical Image Computing, Department of Imaging and Interventional Radiology, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China, 4Bone Quality and Health Centre of the Department of Orthopedics & Traumatology, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China, 5Bone Quality and Health Centre of the Department of Orthopedics & Traumatology, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 6Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong

    Background/Purpose: Metacarpal head directly exposed to intra-articular inflammatory milieu, therefore may lead to abnormal bone remodeling (bone loss and new bone formation). The aims of…
  • Abstract Number: 866 • 2018 ACR/ARHP Annual Meeting

    Patterns of Monosodium Urate Deposition on Dual-Energy CT in Gout Patients on Urate-Lowering Therapy

    Chio Yokose1, Yuqing Zhang2, Nicola Dalbeth3, Jie Wei1, Savvas Nicolaou4, Scott Baumgartner5, Jia Hu6, Maple Fung5 and Hyon K. Choi1, 1Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, 2Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 3University of Auckland, Auckland, New Zealand, 4Radiology, University of British Columbia, Vancouver, BC, Canada, 5Formerly Ardea Biosciences, San Diego, CA, 6Heron Therapeutics, San Diego, CA

    Background/Purpose: Gout is typically characterized as an acute monoarthritis involving the joints of the foot. However, polyarticular involvement develops, especially in advanced disease. Patterns of…
  • Abstract Number: 896 • 2018 ACR/ARHP Annual Meeting

    Pharmacogenomics Study of Predicting Response of TNF Blocker and Medical Image Progression in Chinese Han Ankylosing Spondylitis Population

    Jing Liu1, Weilin Pu1, Qi Zhu2, He Fan1, Wei Wan3, Hejian Zou4, Xiaodong Zhou5, John D. Reveille6, Dongyi He2 and Jiucun Wang1, 1State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China, 2Institute of Arthritis Research, Shanghai Academy of Chinese Medical Sciences, Guanghua Integrative Medicine Hospital, Shanghai, China, 3Division of Rheumatology, Changhai Hospital, Shanghai, China, 4Division of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China, 5Internal Medicine-Rheumatology, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 6McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX

    Background/Purpose: TNF blockers, have been widely used in immune-mediated diseases and many genetic variations predicting treatment response have been described. We applied previously published genetic…
  • Abstract Number: 922 • 2018 ACR/ARHP Annual Meeting

    Anakinra Treatment Prevents Myocardial Mechanical Dysfunction and Inhibits Histologic Evidence of Myocardial Inflammation in the Mouse Model of Kawasaki Disease

    Mark Gorelik1,2, Youngho Lee3, Masanori Abe4, Thomas Andrews5, Jean Patterson1, Magali Noval Rivas4, Gregory Aune5 and Moshe Arditi4, 1Immunology and Virology, Texas Biomedical Research Institute, San Antonio, TX, 2Pediatrics, Baylor College of Medicine, Houston, TX, 3Department of Cell Biology, Hospital for Sick Children, Toronto, ON, Canada, 4Pediatrics, Cedars Sinai, Beverly Hills, CA, 5Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX

    Background/Purpose: Kawasaki disease (KD) is an acute, febrile illness of childhood with sequelae of coronary artery aneurysms and cardiac fibrosis, and is the most common…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 36
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology